These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 7733661
1. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450. Peng HM, Raner GM, Vaz AD, Coon MJ. Arch Biochem Biophys; 1995 Apr 20; 318(2):333-9. PubMed ID: 7733661 [Abstract] [Full Text] [Related]
2. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral. Raner GM, Vaz AD, Coon MJ. Mol Pharmacol; 1996 Mar 20; 49(3):515-22. PubMed ID: 8643091 [Abstract] [Full Text] [Related]
3. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli. Pernecky SJ, Olken NM, Bestervelt LL, Coon MJ. Arch Biochem Biophys; 1995 Apr 20; 318(2):446-56. PubMed ID: 7733676 [Abstract] [Full Text] [Related]
4. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides. Jousserandot A, Boucher JL, Henry Y, Niklaus B, Clement B, Mansuy D. Biochemistry; 1998 Dec 08; 37(49):17179-91. PubMed ID: 9860831 [Abstract] [Full Text] [Related]
5. The NH2-terminal region of rabbit CYP2E1 is not essential for interaction with NADPH-cytochrome P450 reductase. Voznesensky AI, Schenkman JB, Pernecky SJ, Coon MJ. Biochem Biophys Res Commun; 1994 Aug 30; 203(1):156-61. PubMed ID: 8074649 [Abstract] [Full Text] [Related]
6. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T. Mol Pharmacol; 1994 Sep 30; 46(3):568-77. PubMed ID: 7935340 [Abstract] [Full Text] [Related]
7. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether. Köster U, Speerschneider P, Kerssebaum R, Wittmann H, Dekant W. Drug Metab Dispos; 1994 Sep 30; 22(5):667-72. PubMed ID: 7835215 [Abstract] [Full Text] [Related]
8. Mechanism-based inactivation of cytochrome P450 2B4 by aldehydes: relationship to aldehyde deformylation via a peroxyhemiacetal intermediate. Raner GM, Chiang EW, Vaz AD, Coon MJ. Biochemistry; 1997 Apr 22; 36(16):4895-902. PubMed ID: 9125510 [Abstract] [Full Text] [Related]
9. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H, Nakano M, Imai Y, Ueng YF, Guengerich FP, Shimada T. Arch Biochem Biophys; 1996 Jan 15; 325(2):174-82. PubMed ID: 8561495 [Abstract] [Full Text] [Related]
10. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase. Backes WL, Batie CJ, Cawley GF. Biochemistry; 1998 Sep 15; 37(37):12852-9. PubMed ID: 9737863 [Abstract] [Full Text] [Related]
11. Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver. Watanabe K, Matsunaga T, Yamamoto I, Yashimura H. Drug Metab Dispos; 1995 Feb 15; 23(2):261-5. PubMed ID: 7736922 [Abstract] [Full Text] [Related]
12. Aromatization of a bicyclic steroid analog, 3-oxodecalin-4-ene-10-carboxaldehyde, by liver microsomal cytochrome P450 2B4. Vaz AD, Kessell KJ, Coon MJ. Biochemistry; 1994 Nov 22; 33(46):13651-61. PubMed ID: 7947773 [Abstract] [Full Text] [Related]
13. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions. Patten CJ, Koch P. Arch Biochem Biophys; 1995 Mar 10; 317(2):504-13. PubMed ID: 7893169 [Abstract] [Full Text] [Related]
14. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM, Hosea NA, Thompson DV, Lenius JM, Guengerich FP. Arch Biochem Biophys; 1997 Dec 01; 348(1):107-15. PubMed ID: 9390180 [Abstract] [Full Text] [Related]
15. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. Asai H, Imaoka S, Kuroki T, Monna T, Funae Y. J Pharmacol Exp Ther; 1996 May 01; 277(2):1004-9. PubMed ID: 8627510 [Abstract] [Full Text] [Related]
16. Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes. Naiman K, Dracínská H, Martínková M, Sulc M, Dracínský M, Kejíková L, Hodek P, Hudecek J, Liberda J, Schmeiser HH, Frei E, Stiborová M. Chem Res Toxicol; 2008 Aug 01; 21(8):1610-21. PubMed ID: 18624415 [Abstract] [Full Text] [Related]
17. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP. Chem Res Toxicol; 1997 Jan 01; 10(1):91-102. PubMed ID: 9074808 [Abstract] [Full Text] [Related]
18. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Dong MS, Yamazaki H, Guo Z, Guengerich FP. Arch Biochem Biophys; 1996 Mar 01; 327(1):11-9. PubMed ID: 8615680 [Abstract] [Full Text] [Related]
19. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli. Dong J, Porter TD. Arch Biochem Biophys; 1996 Mar 15; 327(2):254-9. PubMed ID: 8619611 [Abstract] [Full Text] [Related]
20. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation. Bestervelt LL, Vaz AD, Coon MJ. Proc Natl Acad Sci U S A; 1995 Apr 25; 92(9):3764-8. PubMed ID: 7731980 [Abstract] [Full Text] [Related] Page: [Next] [New Search]